Table 3.
Potential mediator | Total cohort (N=420) | No persistent wheezing illness (N=231) | Persistent wheezing illness (N=189) | P-value |
---|---|---|---|---|
Potential ETS exposure | 97 (24) | 44 (20) | 53 (28) | 0.04 |
Child <5y in home | 242 (62) | 124 (58) | 118 (66) | 0.12 |
Eczema and/or hay fever | 189 (45) | 88 (38) | 101 (53) | 0.002 |
RSV | 66 (15) | 27 (12) | 39 (21) | 0.01 |
Parent history of asthma | 70 (17) | 31 (13) | 39 (21) | 0.05 |
Furry pet in home | 171 (44) | 97 (46) | 74 (42) | 0.46 |
Anticipated breast milk diet | 187 (45) | 118 (53) | 69 (37) | 0.001 |
Public insurance | 243 (59) | 114 (51) | 129 (69) | <0.001 |
BPD | 279 (66) | 139 (60) | 140 (74) | 0.003 |
Maternal education | 0.03 | |||
Less than high school | 54 (13) | 29 (12) | 25 (13) | |
High school graduate/some college | 206 (49) | 101 (44) | 105 (56) | |
College graduate/graduate school | 160 (38) | 101 (44) | 59 (31) |
Data reported as mean ± SD or N (%). P-value by chi square or t-test.
BPD – bronchopulmonary dysplasia; ETS – environmental tobacco smoke; RSV – respiratory syncytial virus